Multi-PI, inter-programmatic, $2.1M R01 awarded by the National Cancer Institute (NCI) to Theodore Lawrence, MD, PhD, FASTRO, FASCO, and Mukesh Nyati, PhD, for “Development of a first-in-class mEGFR dimerization inhibitor"
May 22, 2020
Major R01 grant from NCI for translational and clinical research
Awarded to Theodore Lawrence, MD, PhD, FASTRO, FASCO, and Mukesh Nyati, PhD, for “Development of a first-in-class mEGFR dimerization inhibitor"